OceanTech Acquisitions I in an 8-K said it deposited $30,000 into trust to extend its completiuon date to May 2. This is the 11th of 12 available monthly extensions the SPAC can deploy as it works to close its merger with Regentis.
The target is an Israel-based regenerative medicine company developing tissue repair solutions.
OceanTech I shareholders approved the deal in February, although final redemptions reached 99.9% and there is a $6 million minimum cash condition to close the deal, according to an amended proxy filed in January. Following the merger vote, the SPAC had about $143,000 remaining in trust. Read more.
Related Posts
Founder SPAC Sets Vote Date on $1.7B Rubicon Technologies Deal
The transaction would deliver to Rubicon approximately $432 million.
IB Acquisition Announces Automatic Unit Separation
The SPAC closed a $115 million IPO last month, with plans to focus on consumer goods, sports and entertainment, and healthcare technology.
Social Leverage I Prices $300M IPO
The SPAC will target the fintech, enterprise software or consumer technology sectors.
Kingswood Acquisition Shareholders Approve 6-Month Extension on Wentworth Deal
The SPAC added that $69,218.35 was deposited into trust in consideration for the first month of the extension.